Candel Therapeutics grants inducement stock options for 30,800 shares at $10.01 each
CADL•Inducement stock options granted to new employees
Candel Therapeutics granted stock options covering 30,800 common shares to three new employees on July 31, 2026.
The options carry an exercise price of $10.01 per share.
Vesting terms are 25% on the first anniversary of each employee’s start date, with the remaining 75% vesting in 36 equal monthly installments.
The awards were issued under the company’s 2025 Inducement Plan, adopted by the board on Dec. 24, 2025.
